Paradigm Biopharmaceuticals Limited (ASX: PAR)
Health Care · Biotechnology · AU
AU$—
— today · — 1Y
Paradigm Biopharmaceuticals Limited (ASX: PAR) operates in the Biotechnology industry within the Health Care sector. The company is valued at $104.36M and employs 12 people.
trading between 0.14 and 0.47.
Tweenvest scores Paradigm Biopharmaceuticals Limited across four factors: quality 30/100, value 43/100. Its strongest factor is value.
PAR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $104.36M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.15
- Dividend yield
- —
- Beta (5Y)
- 0.03
- 52-week high
- AU$0.47
- 52-week low
- AU$0.14
- Avg volume (3M)
- —
- Shares outstanding
- 599.19M
- Employees
- 12
- Next earnings
- —
About Paradigm Biopharmaceuticals Limited
Based in Melbourne, Australia, Paradigm Biopharmaceuticals Limited specializes in the repurposing of existing drugs, developing therapeutic solutions for human health. A central offering is an injectable formulation of pentosan polysulfate sodium, currently undergoing development for the treatment of conditions including osteoarthritis, mucopolysaccharidosis, Ross River virus, chikungunya, and acute respiratory distress syndrome. This company commenced operations in 2014.
- ISIN
- AU000000PAR5
- Founded
- 2014
- Listed since
- Aug 19, 2015
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Maxigen Biotech Inc.TWSE: 1783 | $106.88M | NT$38.10 | +2.83% |
| Tevogen Inc.NasdaqGM: TVGN | $106.69M | $7.15 | +5.46% |
| Vaxart, Inc.OTCPK: VXRT | $105.65M | $0.43 | -0.59% |
| BioGend Therapeutics Co., Ltd.TPEX: 6733 | $104.60M | NT$24.90 | -0.80% |
| Corbus Pharmaceuticals Holdings, Inc.NasdaqCM: CRBP | $104.06M | $4.78 | -11.15% |
| Captor Therapeutics Spolka AkcyjnaWSE: CTX | $103.78M | zł60.00 | -6.25% |
| Shine-On BioMedical Co.,Ltd.TPEX: 6926 | $103.57M | NT$66.50 | -1.04% |
| Bioceltix S.A.WSE: BCX | $102.94M | zł69.60 | -4.53% |
Figures last refreshed Oct 11, 2026.